- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Microbix Biosystems Inc. (MBX)
The Microbix Biosystems Inc. share price today is 0.30, view TSX MBX stock exchange data. Track the latest Microbix Biosystems Inc. share price with real-time updates on MBX stock performance including market cap, day range, 52-week range and dividend yield. Access MBX charts, earnings dates and analyst estimates to support your investment decisions.
0.30
0.00(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.29
0.30
52 wk Range
0.21
0.32
MBX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.290.30
52 wk Range
0.210.32
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MBX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
0.40
Upside
+33.33%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 0.40
(+33.33% Upside)
Microbix Biosystems Inc. Earnings Call Summary for Q3/2026
- Q3 fiscal 2026 revenue rose 17% YoY with gross margin expanding to 54% from 41%, driven by stronger antigen and quality assurance product sales.
- Antigen sales increased 20% and QAPs rose 13% YoY; direct-to-lab B2C sales surged 35% quarter-over-quarter, reducing customer concentration risk.
- Management projects Q4 will be 'considerably stronger' than Q3, targeting break-even at CAD 5.5M quarterly revenue with continued cost discipline.
- Kinlytic urokinase asset on track for FDA meeting before end of 2026 and sBLA filing in 2027; major QAPs agreements expected through calendar 2026.
- Company repurchased 796K shares in Q3 for CAD 209K; cash position at CAD 7.2M with current ratio of 18.08, though remains net cash user at current levels.
Last Updated: 13-08-2026, 08:48 pm
Read Full TranscriptEarnings
Latest Release
13-08-2026
EPS / Forecast
-0.01 / --
Revenue / Forecast
4.06M / 5.2M
Compare MBX to Peers and Sector
Metrics to compare | MBX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMBXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −8.4x | −2.4x | −0.4x | |
PEG Ratio | 0.01 | 0.01 | 0.00 | |
Price/Book | 1.7x | 0.3x | 2.6x | |
Price / LTM Sales | 2.7x | 2.0x | 3.1x | |
Upside (Analyst Target) | 33.3% | 78.5% | 47.8% | |
Fair Value Upside | Unlock | −7.2% | 6.2% | Unlock |
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures a wide range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays, quality assessment, and diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. It also provides customer vial filling services. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.
FAQ
What Is the Microbix Biosystems Inc. (MBX) Share Price Today?
The Microbix Biosystems Inc. share price today is 0.30.
What is the current Microbix Biosystems Inc. (MBX) share price and day range?
As of 15-08-2026, the Microbix Biosystems Inc. share price is 0.30, with a previous close of 0.30. The share price has ranged from 0.29 to 0.30 today, while the 52-week range spans from 0.21 to 0.32.
What Is the Microbix Biosystems Inc. Market Cap?
As of today, Microbix Biosystems Inc. market cap is 41.09M.
What Is the Microbix Biosystems Inc. (MBX) Share Price Target?
The average 12-month share price target for Microbix Biosystems Inc. is 0.40, with a high estimate of 0.4 and a low estimate of 0.4. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +33.33% Upside potential.
What Is Microbix Biosystems Inc.'s Earnings Per Share (TTM)?
The Microbix Biosystems Inc. EPS (TTM) is -0.04.
When Is the Next Microbix Biosystems Inc. Earnings Date?
Microbix Biosystems Inc. will release its next earnings report on 17-12-2026.
From a Technical Analysis Perspective, Is MBX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
What Stock Exchange Does Microbix Biosystems Inc. Trade On?
Microbix Biosystems Inc. is listed and trades on the Toronto Stock Exchange.
What Is the Stock Symbol for Microbix Biosystems Inc.?
The stock symbol for Microbix Biosystems Inc. is "MBX."
How Many Times Has Microbix Biosystems Inc. Stock Split?
Microbix Biosystems Inc. has split 0 times.
How Many Employees Does Microbix Biosystems Inc. Have?
Microbix Biosystems Inc. has 100 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.